title: Phase II trial of idarubicin in patients with pancreatic cancer.
authors.forename: A
authors.initials: A
authors.lastname: Mittelman
authors.forename: G B
authors.initials: GB
authors.lastname: Magill
authors.forename: V
authors.initials: V
authors.lastname: Raymond
authors.forename: C N
authors.initials: CN
authors.lastname: Sternberg
authors.forename: E W
authors.initials: EW
authors.lastname: Cheng
authors.forename: P B
authors.initials: PB
authors.lastname: Sordillo
authors.forename: C W
authors.initials: CW
authors.lastname: Young
mesh_terms: D000328:Adult; D000368:Aged; D003630:Daunorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015255:Idarubicin; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D015255:Idarubicin; D003630:Daunorubicin